Vera Therapeutics, Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
Vera Therapeutics, Inc. (VERA) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $400.90 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2025-11-05
- 2025-09-30: Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month $400.90M.
- 2024-09-30: Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month $201.68M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month |
|---|---|
| 2025-09-30 | $400.90M 10-Q · filed 2025-11-05 |
| 2024-09-30 | $201.68M 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |